celastrol has been researched along with Metabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bishayee, A; Deshmukh, RR; Kumar, P; Kumar, S; Sharma, H | 1 |
| Alberobello, AT; Bagattin, A; Finkel, T; Gavrilova, O; Liu, J; Ma, X; Mueller, E; Skarulis, M; Xu, L | 1 |
1 review(s) available for celastrol and Metabolic Syndrome
| Article | Year |
|---|---|
Pentacyclic triterpenes: New tools to fight metabolic syndrome.
Topics: Animals; Heart; Humans; Insulin Resistance; Liver; Metabolic Syndrome; Muscle, Skeletal; Oleanolic Acid; Oxidative Stress; Pentacyclic Triterpenes; Triterpenes; Ursolic Acid | 2018 |
1 other study(ies) available for celastrol and Metabolic Syndrome
| Article | Year |
|---|---|
Celastrol Protects against Obesity and Metabolic Dysfunction through Activation of a HSF1-PGC1α Transcriptional Axis.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Cells, Cultured; Diet, High-Fat; DNA-Binding Proteins; Energy Metabolism; Fatty Liver; Female; Heat Shock Transcription Factors; Humans; Liver; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Pentacyclic Triterpenes; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Promoter Regions, Genetic; Thermogenesis; Transcription Factors; Triglycerides; Triterpenes | 2015 |